Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis

Agnieszka A Rarok1, Coen A Stegeman, Pieter C Limburg

  • 1Department of Internal Medicine, University Hospital Groningen, The Netherlands. a.a.rarok@med.rug.nl

Insights

Elevated levels of membrane proteinase 3 (mPR3) on neutrophils are linked to increased relapse risk in Wegener granulomatosis (WG) patients with proteinase 3 antineutrophil cytoplasm autoantibodies (PR3-ANCA). This finding suggests mPR3 plays a role in PR3-ANCA vasculitis.

Area of Science:

  • Immunology
  • Rheumatology
  • Cell Biology

Background:

  • Wegener granulomatosis (WG), now known as granulomatosis with polyangiitis, is strongly associated with antineutrophil cytoplasm autoantibodies (ANCA) targeting proteinase 3 (PR3).
  • Relapses in WG are often preceded by rising autoantibody titers, and PR3-ANCA can activate neutrophils.
  • Proteinase 3 (PR3) is found intracellularly but also on the surface of non-stimulated neutrophils (membrane PR3 or mPR3), with variable expression.

Purpose of the Study:

  • To investigate the hypothesis that surface-expressed PR3 on non-stimulated neutrophils interacts with PR3-ANCA, influencing WG clinical manifestations.
  • To evaluate the relationship between mPR3 expression on resting neutrophils and WG clinical features, including relapse susceptibility.

Main Methods:

  • Analysis of mPR3 expression on neutrophils from 89 WG patients in remission and 72 healthy controls.
  • Comparison of mPR3 expression levels and percentages between WG patients and controls.
  • Correlation analysis between mPR3 expression and WG disease extent, manifestations, relapse risk, and relapse rate.

Main Results:

  • No difference in bimodal mPR3 expression was observed between WG patients and controls.
  • WG patients exhibited a higher percentage of mPR3(+) neutrophils and elevated mPR3 expression levels compared to healthy individuals (P = 0.037).
  • In WG patients, elevated mPR3 expression was significantly associated with increased relapse risk (P = 0.021) and relapse rate (P = 0.011), but not disease extent or specific manifestations.

Conclusions:

  • The study supports the hypothesis that membrane-bound PR3 on neutrophils contributes to the pathophysiology of PR3-ANCA-associated vasculitis.
  • Elevated mPR3 expression is a potential biomarker for increased relapse risk in WG patients.
  • Further research into the role of mPR3 in neutrophil activation and vasculitis pathogenesis is warranted.

Related Concept Videos